CMS actuaries foresee a gradual rise in per capita health spending, slowing initially but eventually outpacing economic ...

A systematic review analyzing sleep quality and the impact of zinc supplements reveals glaring gaps in knowledge in this area ...

Two posters presented at the CHEST 2024 annual meeting showed that mepolizumab significantly reduces exacerbations in ...

The Heart Failure Society of America (HFSA) annual meeting 2024 was scheduled to showcase groundbreaking research on the ...

At the CHEST 2024 annual meeting, international respiratory society leaders highlighted the need for global collaboration to ...

Between 2011 and 2020, the Veterans Health Administration spent $78 billion on health services for veterans also enrolled in ...

Experts at CHEST 2024 highlighted significant racial disparities in lung cancer screening, treatment, and outcomes, ...

New data presented at CHEST 2024 in Boston revealed a significant link between obstructive sleep apnea and mental health disorders in middle-aged and older adults.

The suggestive evidence should encourage research into the associations to evaluate the association with stronger evidence.

Recent results from a new diabetes reversal program demonstrate the reliable, sustained benefits of nonpharmacological interventions in the management of diabetes and overall health of patients.

Javed Butler, MD, MPH, MBA, discusses the DAPA ECHO trial data presented at European Society of Cardiology Congress 2024, examining the effects of dapagliflozin on myocardial performance in patients ...

Krunal Patel, MD, Temple University Hospital, highlights CHEST 2024 data revealing why timing matters with acute pulmonary embolism (PE) intervention.